Press release
Bacteriophage Market Size to Boost USD 65.67 Million By 2032 | CAGR 4.2% - Published by Emergen Research
Bacteriophage Market
Bacteriophages have been shown to be a powerful alternative to antibiotics, which are losing efficacy due to rapid growth and spread of resistance-forming genes. Topically, phage therapy has been utilized to treat secondary infected burn-mediated ulcers, infected diabetic foot ulcers, and other unexplained persistently infected wounds. Recent breakthroughs in phage genetic engineering enable the intentional modification of wild phage isolates to make them more suitable for therapeutic reasons by changing host specificity and/or increasing other traits on demand. Phage synthesis processes have evolved dramatically in the previous five years.
The latest research report serves as a perfect example of the precise analysis of the global Bacteriophage Market. It includes the ToC, list of tables and figures, research methodology, geographic segmentation, competitive landscape, future developments, and technological innovation. Moreover, the report offers the latest coverage of the massive impact of the COVID-19 pandemic on the worldwide Bacteriophage industry.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/2245
Drivers of the Bacteriophage Market :
Several factors are driving the growth of the Bacteriophage Market. Notably, the escalating prevalence of antimicrobial-resistant infections, coupled with the diminishing effectiveness of antibiotics, is driving demand for alternative treatment options such as phage therapy. Additionally, advancements in biotechnology and genomics are enabling the identification, characterization, and engineering of phages for targeted and personalized therapies. Moreover, the growing awareness of phage therapy's potential benefits, including its specificity, low toxicity, and potential to overcome antibiotic resistance, is driving interest and investment in phage-based treatments.
Restraints and Challenges
Despite its promising growth prospects, the Bacteriophage Market faces certain restraints. One significant challenge is the limited understanding of phage biology, pharmacokinetics, and safety profiles compared to traditional antibiotics. The complex interactions between phages and bacteria, as well as potential immunological responses in patients, pose challenges for clinical development and regulatory approval of phage-based therapies. Additionally, the lack of standardized manufacturing processes and regulatory pathways for phage products may hinder market growth and adoption. Overcoming these challenges while addressing safety and regulatory concerns remains crucial for the widespread acceptance and commercialization of phage therapy.
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/2245
The report also discusses the key players involved in the market such as:
ADM, Armata Pharmaceuticals, Inc., Proteon Pharmaceuticals, BiomX, Adaptive Phage Therapeutics, Biochimpharm JSC., CYTOPHAGE TECHNOLOGIES INC., ACD Pharma, ELIGO BIOSCIENCE., and Intralytix, Inc.
The report provides a thorough estimation of the overall impact of the pandemic on the Bacteriophage Market and its vital segments. The report also discusses the impact of the pandemic across different regions of the market. It also offers a current and future assessment of the impact of the pandemic on the Bacteriophage Market
Bacteriophage Latest Industry News
On 11 July 2023, Armata Pharmaceuticals, Inc., a biotechnology company focused on antibioticresistant and difficult to treat bacterial infections, announced that it has signed into a credit and security arrangement with Innoviva Strategic Opportunities LLC, a wholly owned subsidiary of Innoviva, Inc. Before transactional fees, the gross proceeds of the credit arrangement upon closing are USD 25 million.
On 12 January 2023, Adaptive Phage Therapeutics, Inc. (APT), a clinical-stage biotechnology company announced the first patient has been dosed in the PHAGE clinical study, an early-stage clinical trial evaluating bacteriophage therapy in adults with cystic fibrosis (CF) who carry Pseudomonas aeruginosa (P. The trial is determining if bacteriophage therapy is safe and capable of reducing the number of bacteria in volunteers' lungs.
Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2245
Bacteriophage Market Segment Analysis :
Emergen Research has segmented the global bacteriophage market on the basis product type, route of administration, application, distribution channel, and region:
o Product Type Outlook (Revenue, USD Million; 2019-2032)
Phage Probiotics
Phage Therapeutics
o Route of Administration Outlook (Revenue, USD Million; 2019-2032)
Oral
Topical
Others
o Application Outlook (Revenue, USD Million; 2019-2032)
Gastroenterology
Respiratory Infections
Skin Infection
Wound Prophylaxis
Urogenital Infection
Others
o Distribution Channel Outlook (Revenue, USD Million; 2019-2032)
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
· Regional Outlook (Revenue, USD Million; 2019-2032)
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of Middle East & Africa
Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/bacteriophage-market
Contact Us:
Eric Lee
Corporate Sales Specialist
14671 110 Avenue, Surrey, British Columbia, V3R2A9
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Custom Intelligence services https://www.emergenresearch.com/custom-intelligence
Growth Consulting Services https://www.emergenresearch.com/growth-consultant
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bacteriophage Market Size to Boost USD 65.67 Million By 2032 | CAGR 4.2% - Published by Emergen Research here
News-ID: 3491886 • Views: …
More Releases from Emergen research
Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion …
The global Internet of Things (IoT) in Healthcare Market was valued at USD 299.05 billion in 2023 and is expected to grow at a CAGR of 16.5% during the forecast period. This growth is fueled by the rising use of connected healthcare devices, increasing demand for early disease detection through remote monitoring, and growing adoption of artificial intelligence (AI) tools within IoT-based healthcare systems.
The market is also benefiting from the…
Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13 …
The global Stem Cell Therapy Market, valued at USD 13.7 billion in 2024, is projected to reach USD 49.2 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.6%. Growth is being fueled by the rising burden of chronic diseases, rapid progress in cell-based studies, and increasing investments in regenerative medicine and personalized healthcare solutions.
Stem cell therapies offer the ability to repair, replace, or restore damaged tissues…
Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophistic …
The global Artificial Intelligence in cybersecurity market size was USD 23.8 Billion in 2023 and is expected to reach a market valuation of USD 29.44 billion by the end of 2024 registering a CAGR of 23.7% during the forecast period. The adoption of Artificial Intelligence (AI) in cybersecurity is rapidly gaining traction as organizations worldwide face increasingly complex and frequent cyber threats. By combining advanced technologies such as Machine Learning…
Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing …
The global regenerative medicine market, valued at USD 34.2 billion in 2024, is set to grow to USD 125.6 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.9%. Growth is being fueled by rising approvals of advanced therapies, strong demand for personalized treatments in cancer and orthopedics, and expanding cell and gene therapy manufacturing across major markets such as North America, Europe, and Asia.
Once seen as…
More Releases for Bacteriophage
Bacteriophage Market 2023 Size, Share, Growth Report 2030
Latest Updated Report 2023, The Global Bacteriophage Market to Growing A CAGR of % during forecast period of 2023-2030. The Market is segmented by Global Bacteriophage Market Breakdown by Application (Clinical Application, Food and Beverages, Phage Display, Phage Therapy, Environmental Application, Veterinary) by Type (dsDNA Bacteriophage, ssDNA Bacteriophage, ssRNA BActeriophage) and by Geography (North America, South America, Europe, Asia Pacific, MEA).
The Bacteriophage Market 2023 Report makes available the current and…
Bacteriophage Therapy Market Size, Industry Share | Forecast 2028
According to Precision Business Insights (PBI) latest report, the global bacteriophage therapy market size is valued at USD 1,242.0 million in 2021, growing at a CAGR of 3.5% during the forecast period 2022-2028. Bacteriophage enable biological agents to combat and eradicate multidrug-resistant bacteria. Phages can eliminate the bacteria that is causing infection when all other antibiotics have failed to treat it, permitting medical experts to save lives. In the US,…
Bacteriophage Market to Discern Steadfast Expansion |Forecast - 2031
Global Bacteriophage Market: Snapshot
Rise in the prevalence of different antibiotic-resistant infections across the globe is projected to help the global bacteriophage market expand at a CAGR of 3.7% in the forecast period of 2020 to 2030.
Bacteriophages, or phages, refer to viruses that selectively target and exclusively kill bacteria. These phases are considered one of the most widespread biological entities that have an ability to efficiently fight and kill multi-drug-resistant bacteria.…
Global bacteriophage market
Global bacteriophage market is anticipated to foresee a compound annual growth rate of 8.1% from 2021 to 2028. Bacteriophage also known as Phage or phage therapy are engineered viruses which are further used to infect and destroy bacteria. Bacteriophage can be used as an alternative of antibiotics as they are much more specific and harm only the bacteria, not the host organism. Overuse of antibiotics exceedingly affects the human body…
Bacteriophage Market Growth and Global Industry Status by 2028
Global Bacteriophage Market: Overview
Bacteriophage, also simply known as phages, are bacterial viruses that infect and feed on bacteria to replicate themselves. Historically, researchers observed their role in limiting bacterial activity but study on phages could not make a mark on bacterial genomics. In recent years, there has been resurgence of interest in phages research across the globe for their critical role in bacterial genetics and molecular biology. Being most abundantly…
Impact of Outbreak of COVID-19 on Bacteriophage Therapy Market
The recent report titled “Covid-19 Impact on Global Bacteriophage Therapy Market Size, Status and Forecast 2020-2026” offered by Researchmoz.us, comprises of a comprehensive investigation into the geographical landscape, industry size along with the revenue estimation of the business. Additionally, the report also highlights the challenges impeding market growth and expansion strategies employed by leading companies in the “Bacteriophage Therapy market”.
This is the most recent report inclusive of the COVID-19 effects…
